Category: drug hub

Additionally, the growing prevalence of these cancers among the aging population is expected to boost demand for advanced therapeutics. Market players are increasingly focusing on local collaborations and clinical research to enhance treatment options tailored to regional patient needs. Sri Lanka’s pancreatic and bile duct cancer drug market is expected to grow steadily, supported by […]

Read More

The expanding pharmaceutical sector and international partnerships are facilitating access to innovative therapies. Challenges such as limited healthcare resources are being addressed through policy reforms and investments in diagnostic facilities. The focus on expanding treatment options and clinical research is expected to accelerate market growth, making Pakistan an emerging hub for pancreatic and bile duct […]

Read More